Epstein Secrets

nts "came after Hungarian officials slammed the actor for 'foolish' remarks about Hungary and suggested that he was repeating the talking points of George Soros, a Hungarian-born U.S. billionaire and Orban foe." The dispute "was sparked by a brief remark Clooney made in an interview with GQ Magazine that was

at he was repeating the talking points of George Soros, a Hungarian-born U.S. billionaire and Orban foe.

airfield County nuclear project but also the troubled financial health of SCANA, according to records and evidence in the case." The charges against Marsh are "the result of a three- year law enforcement investigation led by the FBI and months of behind-the-scenes negotiations between federal prosecuto

hat he was repeating the talking points of George Soros, a Hungarian-born U.S. billionaire and °than foe

nts "came after Hungarian officials slammed the actor for 'foolish' remarks about Hungary and suggested that he was repeating the talking points of George Soros, a Hungarian-born U.S. billionaire and °than foe." The dispute "was sparked by a brief remark Clooney made in an interview with GQ Magazine that wa

airfield County nuclear project but also the troubled financial health of SCANA, according to records and evidence in the case." The charges against Marsh are "the result of a three-year law enforcement investigation led by the FBI and months of behind-the- scenes negotiations between federal prosecuto

ees Can Support Black Lives Matter On The Job. • Soros Organization Giving $220M To Black Groups In Purs

Reform." The New York Times (7/13, Herndon, 18.61M) reports the Open Society Foundations, "the philanthropic group founded by the business magnate George Soros," is set to "announce...that it is investing $220 million in efforts to achieve racial equality in America, a huge financial undertaking that will

the Functional Genomic and Computational Assessments of Threats (FUN GCAT) program "is showing some promise related to the fight against COVID-19." Marsh said, "We pivoted that research, and we went to clinical trials with that a few weeks ago. The early results EFTA00150566 are really positive. It